A Double-Blind, Placebo-Controlled, Randomized, Clinical Trial of the TLR-3 Agonist Rintatolimod in Severe Cases of Chronic Fatigue Syndrome

BACKGROUND: Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a severely debilitating disease of unknown pathogenesis consisting of a variety of symptoms including severe fatigue. The objective of the study was to examine the efficacy and safety of a TLR-3 agonist, rintatolimod (Poly I:...

Descripción completa

Detalles Bibliográficos
Autores principales: Strayer, David R., Carter, William A., Stouch, Bruce C., Stevens, Staci R., Bateman, Lucinda, Cimoch, Paul J., Lapp, Charles W., Peterson, Daniel L., Mitchell, William M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303772/
https://www.ncbi.nlm.nih.gov/pubmed/22431963
http://dx.doi.org/10.1371/journal.pone.0031334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303772/
https://www.ncbi.nlm.nih.gov/pubmed/22431963
http://dx.doi.org/10.1371/journal.pone.0031334

Ejemplares similares